JOSHUA LE: Open Payments
NPI 1427476886 · RENTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 9 payments from 6 companies in 2025. Trend: 2023 $21 · 2024 $45 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Lilly USA, LLC | 2 | $41 |
| Astellas Pharma US Inc | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Wegovy, REXULTI, MOUNJARO, Veozah, ABILIFY MAINTENA, CAPLYTA, AIRSUPRA.
Industry payments across WA — which companies pay providers there.
